Publication & Citation Trends
Publications
0 total
Outcome of patients with accelerated and blast‐phase myeloproliferative neoplasms not eligible for intensive chemotherapy or allogeneic hematopoietic cell transplantation treated by azacitidine alone or in combination—A FIM study
Cited by 1
Semantic Scholar
[Recommendations from the GBMHM and the Fi-LMC for the diagnosis and management of chronic myeloid leukemia].
Cited by 1
Semantic Scholar
ASC4OPT 96-week results: Asciminib once or twice daily continues to be highly efficacious and demonstrates favorable safety in patients with chronic myeloid leukemia and suboptimal response, resistance or intolerance to two or more tyrosine kinase inhibitors
Cited by 0
Semantic Scholar
HLA diversity is associated with TKI response and treatment‐free remission in chronic myeloid leukemia
Cited by 1
Semantic Scholar
Predictive factors for successful treatment-free remission in patients with chronic myeloid leukemia: A pooled analysis
Cited by 0
Semantic Scholar
Additional genetic abnormalities (AGA) and microhomology end-joining DNA repair (MMEJ) signatures influence the outcome of newly diagnosed chronic phase (CP) CML: Ancillary study of the Trial of imatinib after ponatinib induction (TIPI)
Cited by 0
Semantic Scholar
Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia. a randomized national fi-LMC comparative trial of two therapeutic strategies.
Cited by 0
Semantic Scholar
Research Topics
Chronic Myeloid Leukemia Treatments
(93)
Chronic Lymphocytic Leukemia Research
(78)
Eosinophilic Disorders and Syndromes
(45)
Acute Myeloid Leukemia Research
(13)
Acute Lymphoblastic Leukemia research
(12)
Affiliations
Inserm
Université de Versailles Saint-Quentin-en-Yvelines
Université Paris Cité
Karolinska Institutet
Centre Hospitalier Universitaire de La Réunion